IM Cannabis Corp. Common Shares
IMCCIM Cannabis Corp. is a multinational company focused on the production and distribution of medical cannabis products. Established to capitalize on the growing medical marijuana industry, it operates in various jurisdictions, offering a range of cannabis-based treatments and products. The company emphasizes quality cultivation, research, and strategic partnerships to expand its presence in the legal cannabis market.
Company News
IM Cannabis Corp. announced board changes, with two directors resigning and two new directors appointed. Oz Adler was named Board Chairman, and the company plans to explore additional business opportunities to enhance long-term growth.
IM Cannabis Corp. successfully closed a private placement offering, raising approximately US$4.1 million by issuing 2,050,000 units at C$2.7427 per unit, with each unit consisting of a common share or pre-funded warrant and a common share purchase warrant.
IM Cannabis Corp. announced the closing of a non-brokered private placement offering and a debt settlement with its CEO Oren Shuster. The company plans to use the proceeds to repay a loan and improve its financial position.
Cannabis companies and legalization advocates are applauding President Joe Biden's Thursday announcement that formalizes the rescheduling process that will finally move cannabis from the DEA's Schedule I to Schedule III. "This change represents a major leap forward and an opportunity to correct a long-standing wrong which has disproportionally ...
IM Cannabis (IMCC) delivered earnings and revenue surprises of 0% and 14.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
